(Q46732659)

24 December 2017

title

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions (English)

1 reference

24 December 2017

author name string

M R Nelson

1

1 reference

24 December 2017

S-A Bacanu

2

1 reference

24 December 2017

M Mosteller

3

1 reference

24 December 2017

L Li

4

1 reference

24 December 2017

C E Bowman

5

1 reference

24 December 2017

A D Roses

6

1 reference

24 December 2017

E H Lai

7

1 reference

24 December 2017

M G Ehm

8

1 reference

24 December 2017

publication date

26 February 2008

1 reference

24 December 2017

The Pharmacogenomics Journal

published in

1 reference

24 December 2017

volume

9

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

23-33

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/tpj.2008.4

exact match

0 references

cites work

Adverse drug reactions: definitions, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Disease-specific target selection: a critical first step down the right road

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Evaluating and improving power in whole-genome association studies using fixed marker sets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

A new multipoint method for genome-wide association studies by imputation of genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Statistical significance for genomewide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Principal components analysis corrects for stratification in genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Case-only analysis of treatment-covariate interactions in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

A single-nucleotide polymorphism tagging set for human drug metabolism and transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

Design of Case-controls Studies with Unscreened Controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.4

21 January 2018

Identifiers

DOI

10.1038/TPJ.2008.4

1 reference

24 December 2017

PubMed ID

18301416

1 reference

24 December 2017